A traditional Chinese herbal formula called Jianpi Qingre Lishi prescription reduced fatty liver disease in laboratory rats by decreasing liver fat accumulation, normalizing cholesterol and liver enzymes, and reducing inflammation markers in a dose-dependent manner. According to Gram Research analysis, the herbal treatment worked by regulating the miRNA-27/PPARγ molecular pathway that controls fat storage in the liver. However, this is early animal research; human clinical trials are needed before this treatment could be recommended for patients with non-alcoholic fatty liver disease.
Researchers tested a traditional Chinese herbal formula called Jianpi Qingre Lishi prescription on rats with non-alcoholic fatty liver disease (NASH). According to Gram Research analysis, the herbal treatment reduced liver fat buildup, improved cholesterol and liver enzyme levels, and decreased inflammation markers in a dose-dependent manner. The study suggests the herbs work by adjusting specific molecular pathways involved in fat storage and liver health, potentially offering a new natural treatment option for this increasingly common liver condition.
Key Statistics
A 2026 animal study of 120 rats found that the Jianpi Qingre Lishi herbal formula reduced liver fat accumulation and normalized cholesterol and liver enzyme levels in a dose-dependent manner in rats with non-alcoholic fatty liver disease.
Research published in 2026 showed that the herbal formula decreased inflammatory markers TNF-α and IL-6 while increasing anti-inflammatory IL-4 in rats with NASH, suggesting it reduces liver inflammation through multiple pathways.
A 2026 study demonstrated that the herbal treatment corrected abnormal miRNA-27 and PPARγ levels in liver tissue of rats with fatty liver disease, identifying a specific molecular mechanism for the formula’s therapeutic effects.
The Quick Take
- What they studied: Whether a traditional Chinese herbal formula could treat non-alcoholic fatty liver disease (NASH) by examining how it affects liver fat, inflammation, and specific molecular pathways in the liver.
- Who participated: 120 laboratory rats divided into six groups: a healthy control group, a disease model group, three groups receiving different doses of the herbal treatment, and a positive control group receiving standard treatment.
- Key finding: The herbal formula reduced liver fat accumulation, normalized cholesterol and liver enzyme levels, and decreased inflammatory markers in a dose-dependent manner—meaning higher doses produced better results.
- What it means for you: This research suggests a traditional herbal approach may help treat fatty liver disease, but these are early animal studies. Human clinical trials are needed before this treatment could be recommended for patients. Do not self-treat NASH without consulting your doctor.
The Research Details
This was an animal research study using 120 laboratory rats to test a traditional Chinese herbal formula called Jianpi Qingre Lishi prescription (JQLP). The researchers divided the rats into six groups: a healthy control group eating normal food, a disease model group, three treatment groups receiving different doses of the herbal formula, and a positive control group receiving standard medical treatment.
To create fatty liver disease in the rats, researchers fed most groups a special diet lacking methionine and choline—nutrients that normally protect the liver. The rats receiving the herbal treatment got different amounts (low, medium, or high doses) mixed into their food. After the treatment period, scientists collected blood samples to measure cholesterol, liver enzymes, and inflammation markers. They also examined liver tissue under a microscope to see how much fat had accumulated and how much inflammation was present.
The researchers used advanced molecular techniques to measure specific genetic markers (miRNA-27) and proteins (PPARγ) that control how the liver stores fat and manages inflammation. This allowed them to understand not just whether the herbs worked, but how they worked at the cellular level.
Understanding the molecular mechanism—the specific way the herbs work—is important because it helps scientists determine whether the treatment might work in humans and what dose would be most effective. By measuring both the physical changes in the liver and the molecular changes, researchers can build a stronger case for moving toward human clinical trials.
This study has several strengths: it used a reasonable sample size (120 animals), included proper control groups for comparison, measured multiple relevant outcomes, and examined the molecular mechanisms. However, as an animal study, results may not directly translate to humans. The study was published in a peer-reviewed journal, which means other experts reviewed the methods and findings. The researchers used standard, well-established techniques for measuring liver health and molecular markers.
What the Results Show
The herbal formula significantly reduced fatty liver disease in rats fed a diet that causes NASH. Rats receiving medium and high doses of the herbal treatment showed substantially lower blood glucose levels compared to untreated disease rats. The liver tissue of treated rats showed much less fat accumulation, better-organized liver cell structure, and reduced inflammatory cell infiltration—all in a dose-dependent pattern, meaning higher doses produced better results.
The herbal treatment also normalized multiple blood markers of liver health. Rats with untreated fatty liver disease had elevated cholesterol, triglycerides, and liver enzymes (ALT and AST), along with low beneficial cholesterol (HDL). After herbal treatment, these values returned toward normal levels. The formula was particularly effective at reducing harmful inflammation markers: it decreased TNF-α and IL-6 (inflammatory proteins) while increasing IL-4 (an anti-inflammatory protein).
At the molecular level, the herbal formula worked by adjusting the miRNA-27/PPARγ axis—a cellular control system that regulates fat storage in the liver. Rats with untreated fatty liver disease showed abnormal levels of these molecular markers, but the herbal treatment corrected these imbalances in a dose-dependent manner.
The study found that the herbal formula’s effects were dose-dependent, meaning the medium and high doses were more effective than the low dose. This suggests there may be an optimal therapeutic dose. The positive control group (receiving standard medical treatment) showed similar improvements to the high-dose herbal group, suggesting the herbal formula performed comparably to conventional treatment in this animal model.
This research builds on growing interest in traditional Chinese medicine for liver diseases. Previous studies have suggested that herbal formulas may help with fatty liver disease, but this study is notable for identifying a specific molecular mechanism (the miRNA-27/PPARγ pathway) through which the herbs appear to work. The findings align with emerging research showing that regulating this particular molecular pathway is important for treating NASH.
This study was conducted entirely in laboratory rats, not humans. Animal models don’t always translate to human biology, and rats metabolize substances differently than people do. The study didn’t test the herbal formula in combination with lifestyle changes like diet and exercise, which are important for treating NASH in humans. The research also didn’t examine potential side effects or interactions with other medications. Finally, this is a single study; results need to be confirmed by other independent research teams before drawing firm conclusions.
The Bottom Line
Based on this animal research, the Jianpi Qingre Lishi herbal formula shows promise for treating non-alcoholic fatty liver disease. However, confidence level is LOW because this is preliminary animal research. Do not use this herbal formula to self-treat NASH without consulting a healthcare provider. If you have fatty liver disease, work with your doctor on proven treatments including weight loss, reduced sugar intake, and regular exercise. This research suggests herbal approaches warrant further investigation in human clinical trials.
People with non-alcoholic fatty liver disease (NASH) or at risk for it should be aware of this research, but should not attempt self-treatment. Healthcare providers researching natural treatment options for NASH should monitor this research as it progresses to human trials. Researchers in traditional Chinese medicine and hepatology should consider this work as a foundation for further investigation.
This is early-stage research. If human clinical trials begin soon, it would typically take 3-5 years to complete Phase 1 and Phase 2 trials to establish safety and initial effectiveness. Full approval for medical use would require additional years of research. Realistic timeline for potential clinical availability: 5-10 years at minimum, assuming positive results in human studies.
Frequently Asked Questions
Can I use this Chinese herbal formula to treat my fatty liver disease?
Not yet. This 2026 study was conducted only in laboratory rats. Human clinical trials are needed to establish safety and effectiveness in people. Consult your doctor about proven NASH treatments including weight loss, reduced sugar, and regular exercise before considering any herbal supplements.
How does the Jianpi Qingre Lishi formula work to treat fatty liver?
According to the 2026 research, the herbal formula regulates the miRNA-27/PPARγ molecular pathway that controls fat storage in liver cells. It also reduces inflammatory proteins (TNF-α and IL-6) while increasing anti-inflammatory proteins, helping restore liver health through multiple mechanisms.
What is non-alcoholic fatty liver disease and why is it serious?
NASH is excessive fat buildup in the liver unrelated to alcohol consumption. It causes inflammation and liver damage, potentially leading to cirrhosis and liver failure. It’s increasingly common with obesity and metabolic syndrome. Early treatment with lifestyle changes and emerging therapies is important.
When will this herbal treatment be available for human use?
This is preliminary research. If human clinical trials begin soon, realistic timeline for potential medical availability is 5-10 years minimum. Researchers must first conduct safety trials, then effectiveness trials, before regulatory approval. Monitor medical journals for updates on clinical trial progress.
Are there proven treatments for fatty liver disease right now?
Yes. Weight loss of 5-10% significantly improves NASH. Reducing refined sugars, increasing physical activity, and limiting alcohol are evidence-based approaches. Some medications like pioglitazone and vitamin E show promise. Work with your doctor to develop a personalized treatment plan.
Want to Apply This Research?
- If a user has NASH or fatty liver disease, they could track liver enzyme levels (ALT and AST) from regular blood work, cholesterol panels, and triglyceride levels monthly or quarterly. They could also track inflammatory markers if their doctor orders them. This creates a measurable baseline to discuss with their healthcare provider.
- Users could use the app to log daily habits that support liver health while this research progresses: water intake, exercise minutes, refined sugar consumption, and alcohol intake (if applicable). They could set reminders for regular doctor appointments to monitor liver health markers.
- Create a long-term health tracking dashboard showing trends in liver enzyme levels, cholesterol, triglycerides, and weight over 3-6 month intervals. Users could share this data with their healthcare provider to assess whether current treatment approaches are working and to discuss emerging research like this herbal formula study.
This research describes an animal study of a traditional Chinese herbal formula for non-alcoholic fatty liver disease (NASH). These findings have not been tested in humans and should not be used for self-treatment. If you have NASH or suspect you have fatty liver disease, consult your healthcare provider about evidence-based treatment options including lifestyle modifications and FDA-approved medications. Do not discontinue prescribed medications or begin herbal supplements without medical supervision. This article is for informational purposes only and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.